AAAAAA
Results:
1-16
|
Results: 16
Authors:
Dweck, A
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Elstein, D
Citation: A. Dweck et al., Wandering spleen in a young girl with Gaucher disease, ISR MED ASS, 3(8), 2001, pp. 623-624
Authors:
Goitein, O
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Melzer, E
Kerem, E
Zimran, A
Citation: O. Goitein et al., Lung involvement and enzyme replacement therapy in Gaucher's disease, QJM-MON J A, 94(8), 2001, pp. 407-415
Authors:
Pines, G
Morag, A
Elstein, D
Abrahamov, A
Zimran, A
Citation: G. Pines et al., Viral infections and phenotypic heterogeneity in Gaucher disease, BL CELL M D, 27(2), 2001, pp. 358-361
Authors:
Pines, G
Morag, A
Elstein, D
Abrahamov, A
Zimran, A
Citation: G. Pines et al., Viral infections and phenotypic heterogeneity in Gaucher disease, BL CELL M D, 27(2), 2001, pp. 358-361
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Gaucher's disease, LANCET, 358(9278), 2001, pp. 324-327
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher - Reply, BR J HAEM, 113(4), 2001, pp. 1086-1087
Authors:
Lebel, E
Itzchaki, M
Elstein, D
Hadas-Halpern, I
Abrahamov, A
Zimran, A
Citation: E. Lebel et al., Managing Gaucher, ISR MED ASS, 2(3), 2000, pp. 260-260
Authors:
Zimran, A
Abrahamov, A
Elstein, D
Citation: A. Zimran et al., Children with type I Gaucher disease: Growing into adulthood with and without enzyme therapy, ISR MED ASS, 2(2), 2000, pp. 80-81
Authors:
Iancovici-Kidon, M
Sthoeger, D
Abrahamov, A
Volach, B
Beutler, E
Gelbart, T
Barak, Y
Citation: M. Iancovici-kidon et al., A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes, BL CELL M D, 26(6), 2000, pp. 567-571
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Withdrawal of enzyme replacement therapy in Gaucher's disease, BR J HAEM, 110(2), 2000, pp. 488-492
Authors:
Lebel, E
Itzchaki, M
Elstein, D
Hadas-Halpern, I
Abrahamov, A
Zimran, A
Citation: E. Lebel et al., Skeletal manifestations in Gaucher disease: Presentation and treatment, ISR MED ASS, 1(4), 1999, pp. 267-271
Authors:
Barak, V
Acker, M
Nisman, B
Kalickman, I
Abrahamov, A
Zimran, A
Yatziv, S
Citation: V. Barak et al., Cytokines in Gaucher's disease, EUR CYTOKIN, 10(2), 1999, pp. 205-210
Authors:
Veinot, JP
Elstein, D
Hanania, D
Abrahamov, A
Srivatsa, S
Zimran, A
Citation: Jp. Veinot et al., Gaucher's disease with valve calcification: Possible role of Gaucher cells, bone matrix proteins and integrins, CAN J CARD, 15(2), 1999, pp. 211-216
Authors:
Gillis, S
Hyam, E
Abrahamov, A
Elstein, D
Zimran, A
Citation: S. Gillis et al., Platelet function abnormalities in Gaucher disease patients, AM J HEMAT, 61(2), 1999, pp. 103-106
Authors:
Gielchinsky, Y
Elstein, D
Hadas-Halpern, I
Lahad, A
Abrahamov, A
Zimran, A
Citation: Y. Gielchinsky et al., Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease, BR J HAEM, 106(3), 1999, pp. 812-816
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Recommendations for diagnosis, evaluation, and monitoring of patients withGaucher disease, ARCH IN MED, 159(11), 1999, pp. 1254-1255
Risultati:
1-16
|